AP1 regulation of proliferation and initiation of apoptosis in erythropoietin-dependent erythroid cells

Molecular and Cellular Biology

Volumn 18, Issue 7, 1998, Pages 3699-3707

  Jacobs Helber, Sarah M ^a   Wickrema, Amittha ^b   Birrer, Michael J ^c   Sawyer, Stephen T ^a,d  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; COLONY FORMING UNIT; DNA BINDING; DNA SEQUENCE; ERYTHROID CELL; NONHUMAN; ONCOGENE C JUN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALIA;

EID: 0031806003     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.18.7.3699     Document Type: Article

References (74)

1. Adachi, K., and H. Saito. 1992. Induction of junB expression, but not c-jun, by granulocyte colony-stimulating factor or macrophage colony-stimulating factor in the proliferative response of human myeloid leukemia cells. J. Clin. Invest. 89:1657-1661.
2. Adler, V., S. Y. Fuchs, J. Kim, A. Kraft, M. P. King, J. Pelling, and Z. Ronai. 1995. Jun-NH2-terminal kinase activation mediated by UV-induced DNA lesions in melanoma and fibroblast cells. Cell Growth Differ. 6:1437-1446
3. Alani, R., P. H. Brown, B. Binetruy, H. Dosaka, R. K. Rosenberg, P. Angel, M. Karin, and M. J. Birrer. 1991. The transactivating function of the c-Jun proto-oncoprotein is required for cotransformation of rat embryo cells. Mol. Cell. Biol. 11:6286-6295.
4. Angel, P., E. A. Allegretto, S. T. Okino, K. Hattori, W. J. Boyle, T. Hunter, and M. Karin. 1988. Oncogene jun encodes a sequence-specific trans-activator similar to AP-1. Nature 332:166-171.
5. Anger, P., M. Imagawa, R. Chiu, B. Stein, R. J. Imbra, H. J. Rahmsdorf, C. Jonat P. Herrlich, and M. Karin. 1987. Phorbolester-inducible genes contain a common cis-element recognized by the TPA-modulated trans-acting factor. Cell 49:729-739.
6. Assefa, Z., M. Garmyn, R. Bouillon, W. Merlevede, J. R. Vandenheede, and P. Agostinis. 1997. Differential stimulation of ERK and JNK activities by ultraviolet B irradiation and epidermal growth factor in human keratinocytes. J. Invest. Dermatol. 108:886-891.
7. Atfi, A., S. Djelloul, E. Chastre, R. R. Davis, and C. Gespach. 1997. Evidence for a role of Rho-like GTPases and stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) in transforming growth factor β-mediated signaling. J. Biol. Chem. 272:1429-1432.
8. Bossy-Wetzel, E., L. Bakiri, and M. Yaniv. 1997. Induction of apoptosis by the transcription factor c-Jun. EMBO J. 16:1695-1709.
9. Brown, P. H., R. Alani, L. H. Preis, E. Szabo, and M. J. Birrer. 1993. Suppression of oncogene-induced transformation by a deletion mutant of c-jun. Oncogene 8:877-886.
10. Brown, P. H., T. K. Chen, and M. J. Birrer. 1994. Mechanism of action of a dominant-negative mutant of c-Jun. Oncogene 9:791-799.
11. 2-terminal kinase regulation of the apoptotic response of small cell lung cancer cells to ultraviolet radiation. J. Biol. Chem. 272:10110-10116.
12. Chen, T. K., L. M. Smith, D. K. Gebhardt, M. J. Birrer, and P. H. Brown. 1996. Activation and inhibition of the AP-1 complex in human breast cancer cells. Mol. Carcinog. 15:215-226.
13. Chen, Y. R., C. F. Meyer, and T. H. Tan. 1996. Persistent activation of c-Jun N-terminal kinase 1 (JNK1) in gamma radiation-induced apoptosis. J. Biol. Chem. 271:631-634.
14. Chin, H., N. Nakamura, R. Kamiyama, N. Miyasaka, J. N. Ihle, and O. Miura. 1996. Physical and functional interactions between Stat5 and the tyrosine-phosphorylated receptors for erythropoietin and interleukin-3. Blood 88:4415-4425.
15. Cohen, D. R., and T. Curran. 1988. fra-1: a serum-inducible, cellular immediate-early gene that encodes a Fos-related antigen. Mol. Cell. Biol. 8:2063-2069.
16. Curran T., and N. M. Teich. 1982. Candidate product of the FBJ murine osteosarcoma virus oncogene: characterization of a 55,000-dalton phosphoprotein. J. Virol. 42:114-122.
17. Damen, J. E., L. Liu, R. L. Cutler, and G. Krystal. 1993. Erythropoietin stimulates the tyrosine phosphorylation of Shc and its association with Grb2 and a 145-Kd tyrosine phosphorylated protein. Blood 82:2296-2303
18. Damen, J. E., A. L. Mui, J. L. Puil, T. Pawson, and G. Krystal. 1993. Phosphatidylinositol 3-kinase associates, via its Src homology 2 domains, with the activated erythropoietin receptor. Blood 81:3204-3210.
19. Damen, J. E., H. Wakao, A. Miyajima, J. Krosl, R. K. Humphries, R. L. Cutler, and G. Krystal. 1995. Tyrosine 343 in the erythropoietin receptor positively regulates erythropoietin-induced cell proliferation and Stat5 activation. EMBO J. 14:5557-5568.
20. Deng, T., and M. Karin. 1993. JunB differs from c-Jun in its DNA-binding and dimerization domains, and represses c-Jun by formation of inactive heterodimers. Genes Dev. 7:479-490.
21. Devemy, E., C. Billat, and B. Haye. 1997. Activation of rat-1 and mitogen-activated protein kinases by erythropoietin and inositolphosphate-glycan in normal erythroid progenitor cells: involvement of protein kinase C. Cell. Signalling, 9:41-46.
22. Domann, F. E., J. P. Levy, M. J. Birrer, and G. T. Bowden. 1994. Stable expression of a c-JUN deletion mutant in two malignant mouse epidermal cell lines blocks tumor formation in nude mice. Cell Growth Differ. 5:9-16.
23. Dorsey, M. J., H. J. Tae, K. G. Sollenberger, N. T. Mascarenhas, L. M. Johansen, and E. J. Taparowsky. 1995. B-ATF: a novel human bZIP protein that associates with members of the AP-1 transcription factor family. Oncogene 11:2255-2265.
24. Foltz, I. N., and J. W. Schrader. 1997. Activation of the stress-activated protein kinases by multiple hematopoietic growth factors with the exception of interleukin-4. Blood 89:3092-3096.
25. Francastel, C., R. Groisman, C. M. Pfarr, and J. Robert-Lezenes. 1994. Antisense c-jun overcomes a differentiation block in a murine erythroleukemia cell line. Oncogene 9:1957-1964.
26. Franklin, C. C., V. Sanchez, F. Wagner, J. R. Woodgett, and A. S. Kraft. 1992. Phorbol ester-induced amino-terminal phosphorylation of human JUN but not JUNB regulates transcriptional activation. Proc. Natl. Acad. Sci. USA 89:7247-7251.
27. Frey, R. S., and K. M. Mulder. 1997. TGFbeta regulation of mitogen-activated protein kinases in human breast cancer cells. Cancer Lett. 117:41-50.
28. Gajate, C., M. T. Alonso, T. Schimmang, and F. Mollinedo. 1996. C-Fos is not essential for apoptosis. Biochem. Biophys. Res. Commun. 218:267-272.
29. He, T. C., N. Jiang, H. Zhuang, and D. M. Wojchowski. 1995. Erythropoietin-induced recruitment of Shc via a receptor phosphotyrosine-independent, Jak2-associated pathway. J. Biol. Chem. 270:11055-11061.
30. He, T. C., H. Zhuang, D. E. Quelle, and D. M. Wojchowski. 1993. Association of the p85 regulatory subunit of phosphatidylinositol 3-kinase with an essential erythropoietin receptor subdomain. Blood 82:3530-3538.
31. Hirai, S. I., R. P. Ryseck, F. Mechta, R. Bravo, and M. Yaniv, 1989. Charcterization of Jun D: a new member of the jun oncogene family. EMBO J. 8:1433-1439.
32. Hsu, J. C., D. E. Cressman, and R. Taub. 1993. Promoter-specific trans-activation and inhibition mediated by JunB. Cancer Res. 53:3789-3794.
33. Jacobs-Helber, S. M., K. Penta, Z. H. Sun, A. Lawson, and S. T. Sawyer. 1997. Distinct signaling from stem cell factor and erythropoietin in HCD57 cells. J. Biol. Chem. 272:6850-6853.
34. Johnson, N. L., A. M. Gardner, K. M. Diener, C. A. Lange-Carter, J. Gleavy, M. B. Jarpe, A. Minden, M. Karin, L. I. Zon, and G. L. Johnson. 1996. Signal transduction pathways regulated by mitogen-activated/extracellular response kinase kinase kinase induce cell death. J. Biol. Chem. 271:3229-3237.
35. Joneja, B., and D. M. Wojchowski. 1997. Mitogenic signaling and inhibition of apoptosis via the erythropoietin receptor box-1 domain. J. Biol. Chem. 272:11176-11184.
36. Kallunki, T., T. Deng, M. Hibi, and M. Karin. 1996. c-Jun can recruit JNK to phosphorylate dimerization partners via specific docking interactions. Cell 87:999-939.
37. Kang, L. Y. and Y. C. Yang. 1995. Activation of junB and c-myc primary response genes by interleukin 9 in a human factor-dependent cell line. J. Cell. Physiol. 163:623-630.
38. Karin, M., Z. G. Liu, and E. Zandi. 1997. AP-1 function and regulation. Curr. Opin. Cell Biol. 9:240-246.
39. Kelly, L. L., M. J. Koury, M. C. Bondurant, S. T. Koury, S. T. Sawyer, and A. Wickrema. 1993. Survival or death of individual proerythroblasts results from differing erythropoietin sensitivities: a mechanism for controlled rates of erythrocyte production. Blood 82:2340-2352.
40. Klingmüller, U., H. Wu, J. G. Hsiao, A. Toker, B. C. Duckworth, L. C. Cantley, and H. F. Lodish. 1997. Identification of a novel pathway important for proliferation and differentiation of primary erythroid progenitors. Proc. Natl. Acad. Sci. USA 94:3016-3021.
41. Koury M. J., and M. C. Bondurant. 1992. The molecular mechanism of erythropoietin action. Eur. J. Biochem. 210:649-663.
42. Lacronique V., P. Varlet, P. Mayeux, A. Porteau, S. Gisselbrecht, A. Kahn, and C. Lacombe. 1997. Bcl-2 targeted overexpression into the erythroid lineage of transgenic mice delays but does not prevent the apoptosis of erythropoietin-deprived erythroid progenitors. Blood 90:3050-3056.
43. Latinis, K. M., and G. A. Koretzky. 1996. Fas ligation induces apoptosis and Jun kinase activation independently of CD45 and Lck in human T cells. Blood 87:871-875.
44. Maniatis, T., E. F. Fritsch, and J. Sambrook. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
45. Miura, O., Y. Miura, N. Nakamura, F. W. Quelle, B. A. Witthuhn, J. N. Ihle, and N. Aoki. 1994. Induction of tyrosine phosphorylation of Vav and expression of Pim-1 correlates with Jak2-mediated growth signaling from the erythropoietin receptor. Blood 84:4135-4141.
46. Miura, Y., O. Miura, J. N. Ihle, and N. Aoki. 1994. Activation of the mitogen-activated protein kinase pathway by the erythropoietin receptor. J. Biol. Chem. 269:29962-29969.
47. Nagata, Y., E. Nishida, and K. Todokoro. 1997. Activation of JNK signaling pathway by erythropoietin, thrombopoietin, and interleukin-3. Blood 89: 2664-2669.
48. Nishina, H., H. Sato, T. Suzuki, M. Sato, and H. Iba. 1990. Isolation and characterization of fra-2, an additional member of the fos gene family. Proc. Natl. Acad. Sci. USA 87:3619-3623.
49. Okamoto, K., K. Fujisawa, T. Hasunuma, T. Kobata, T. Sumida, and K. Nishioka. 1997. Selective activation of the JNK/AP-1 pathway in FAS-mediated apoptosis of rheumatoid arthritis synoviocytes. Arthritis Rheum. 40: 919-926.
50. Patel, H. R., and A. J. Sytkowski. 1995. Erythropoietin activation of AP1 (Fos/Jun). Exp. Hematol. 23:619-625.
51. Payne, C. M., C. Bernstein, and H. Bernstein. 1995. Apoptosis overview emphasizing the role of oxidative stress, DNA damage and signal-transduction pathways. Leuk. Lymphoma 19:43-93.
52. Penta, K., and S. T. Sawyer. 1995. Erythropoietin induces the tyrosine phosphorylation, nuclear translocation, and DNA binding of STAT1 and STAT5 in erythroid cells. J. Biol. Chem. 270:31282-31287.
53. Roffler-Tarlov, S., J. J. Brown, E. Tarlov, J. Stolarov, D. L. Chapman, M. Alexiou, and V. E. Papaioannou. 1996. Programmed cell death in the absence of c-Fos and c-Jun. Development 122:1-9.
54. Ryder, K., A. Lanahan, E. Perez-Albuerne, and D. Nathans. 1988. Jun-D: a third member of the Jun family. Proc. Natl. Acad. Sci. USA 86:1500-1503.
55. Sawyer, S. T., and K. Penta. 1994. Erythropoietin cell biology. Hematol. Oncol. Clin. N. Am. 8:895-911.
56. Sawyer, S. T., and K. Penta. 1996. Association of JAK2 and STAT5 with erythropoietin receptors - role of receptor phosphorylation in erythropoietin signal transduction. J. Biol. Chem. 271:32430-32437.
57. Schlingensiepen, R., H. Terlau, W. Brysch, and K. H. Schlingensiepen. 1994. Differential expression of c-jun, junB and junD in rat hippocampal slices. Neuroreport 6:101-104.
58. Schutte, J., J. D. Minna, and M. J. Birrer. 1989. Deregulated expression of human c-jun transforms primary rat embryo cells in cooperation with an activated c-Ha-ras gene and transforms Rat-la cells as a single gene. Proc. Natl. Acad. Sci. USA 86:2257-2261.
59. Silva, M., D. Grillot, A. Benito, C. Richard, G. Nunez, and J. L. Fernandez-Luna. 1996. Erythropoietin can promote erythroid progenitor survival by repressing apoptosis through BclXL and Bcl-2. Blood 88:1576-1582.
60. Tauchi, T., G. S. Feng, R. Shen, M. Hoatlin, G. Bagby, D. Kabat, L. Lu, and H. E. Broxmeyer. 1995. Involvement of SH2-containing phosphotyrosine phosphatase Syp in erythropoietin receptor signal transduction pathways. J. Biol. Chem. 270:5631-5635.
61. Tauchi, T., K. Toyama, G. S. Feng, H. E. Broxmeyer, and G. Krystal. 1996. Tyrosine 425 within the activated erythropoietin receptor binds Syp, reduces the erythropoietin required for Syp tyrosine phosphorylation, and promotes mitogenesis. Blood 87:4495-4501.
62. Terada, K., Y. Kaziro, and T. Satoh. 1997. Ras-dependent activation of c-Jun N-terminal kinase/stress-activated protein kinase in response to interleukin-3 stimulation in hematopoietic BaF3 cells. J. Biol. Chem. 272:4544-4548.
63. Teslolin, L., C. Carson, Y. Z. Wang, P. R. Walker, U. Armato, and M. Sikorska. 1997. Jun and JNK kinase are activated in thymocytes in response to VM26 and radiation but not glucocorticoids. Exp. Cell Res. 230:220-232.
64. Thomas, P. S. 1980. Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc. Natl. Acad. Sci. USA 77:5201-5205.
65. Todokoro, K., M. Sugiyama, E. Nishida, and K. Nakaya. 1994. Activation of mitogen-activated protein kinase cascade through erythropoietin receptor. Biochem. Biophys. Res. Commun. 203:1912-1919.
66. Verheij, M., R. Bose, X. H. Lin, B. Yao, W. D. Jarvis, S. Grant, M. J. Birrer, E. Szabo, L. I. Zon, and J. M. Kyriakis. 1996. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature 380:75-79.
67. Wakao, H., F. Gouilleux, and B. Groner. 1995 Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response. EMBO J. 14:854-855.
68. Wickrema, A., S. B. Krantz, J. C. Winkelmann, and M. C. Bondurant. 1992. Differentiation and erythropoietin receptor gene expression in human erythroid progenitor cells. Blood 80:1940-1949.
69. Witthuhn, B. A., F. W. Quelle, O. Silvennoinen, T. Yi, B. Tang, O. Miura, and J. N. Ihle. 1993. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell 74:227-236.
70. Xia, Z., M. Dickens, J. Raingeaud, R. J. Davis, and M. E. Greenberg. 1995. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326-1331.
71. Zerial, M., L. Toschi, R. P. Ryseck, M. Schuermann, R. Muller, and R. Bravo. 1989. The product of a novel growth factor activated gene, fos-B, interacts with Jun proteins enhancing their DNA binding activity. EMBO J. 8:805-815.
72. Zhao, B. H., W. P. Yu, M. Qian, M. Simmons-Menchaca, P. H. Brown, M. J. Birrer, B. G. Sanders, and K. Kline. 1997. Involvement of activator protein-1 (AP-1) in induction of apoptosis by vitamin E succinate in human breast cancer cells. Mol. Carcinog. 19:180-190.
73. Zhuang, H., Z. Niu, T.-C. He, S. V. Patel, and D. M. Wojchowski. 1995. Erythropoietin-dependent inhibition of apoptosis is supported by carboxyl-truncated receptor forms and blocked by dominant-negative forms of Jak2. J. Biol. Chem. 270:14500-14504.
74. Zhuang, H., S. V. Patel, T. C. He, Z. Niu, and D. M. Wojchowski. 1994. Dominant negative effects of a carboxy-truncated Jak2 mutant on Epo-induced proliferation and Jak2 activation. Biochem. Biophys. Res. Commun. 204:278-283.